Predictive role of CCND1, FGFR1 gene amplifications and PIK3CA mutations for endocrine therapy of primary metastatic breast cancer . (2021). Voprosy Onkologii, 67(5), 646-657. https://doi.org/10.37469/0507-3758-2021-67-5-646-657